Rating Change
Keybanc analysts reiterated a Overweight rating on ResMed Inc. (NYSE:RMD) on August 07, 2026.
reiterateNYSE:RMD
Keybanc Reiterates Overweight Rating on ResMed Inc. (RMD)
Rating Change Keybanc analysts reiterated a Overweight rating on ResMed Inc. (NYSE:RMD) on August 07, 2026. Market Context ResMed Inc.
At a glance
Key takeaways
- Keybanc reiterated an Overweight rating on ResMed Inc. (RMD) on August 7, 2026, with the stock trading at $212.31 and a market capitalization of $37.0 billion.
- ResMed's stock has declined 8.5% over the past 52 weeks despite the positive analyst rating.
- Among the 10 most recent analyst ratings, 5 are Buy and 5 are Hold with no Sell ratings, indicating mixed but generally positive sentiment.
Market Context
ResMed Inc. operates in the Healthcare sector. The stock currently trades at $212.31 with a market capitalization of $37.0B. The stock has declined 8.5% over the past 52 weeks.
Analyst coverage from Keybanc provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ResMed Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ResMed Inc.
Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 07, 2026 | Wells Fargo | Equal-Weight | N/A |
| Aug 07, 2026 | Keybanc | Overweight | N/A |
| Jul 15, 2026 | Mizuho | Outperform | N/A |
| Jul 13, 2026 | Citigroup | Neutral | N/A |
| Jul 10, 2026 | Jefferies | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View RMD Stock Page
Frequently Asked Questions
What does a Overweight rating mean for RMD?
A Overweight rating from Keybanc reflects the analyst's outlook on ResMed Inc. (NYSE:RMD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RMD forecast page.
